Standard Biotools (LAB) Change in Account Payables (2010 - 2026)
Standard Biotools (LAB) reported Change in Account Payables of -$1.2 million for Q1 2026, down 111.76% year-over-year from $10.4 million in Q1 2025, and down 287.44% quarter-over-quarter from $653000.0 in Q4 2025.
Standard Biotools (LAB) Change in Account Payables (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 17 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$1.2 million, down 111.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 154.79% YoY), and the FY2025 annual result was $2.4 million, up 118.78% from the prior year.
- Change in Account Payables declined to -$1.2 million in Q1 2026 per LAB's latest filing, from $653000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.1 million in Q4 2023 and troughed at -$10.3 million in Q1 2024.
- A 5-year average of -$760000.0 and a median of -$88000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables plunged 772.13% in 2024, then jumped 842.05% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$1.3 million in 2022, then jumped by 264.86% to $2.1 million in 2023, then plunged by 104.19% to -$88000.0 in 2024, then jumped by 842.05% to $653000.0 in 2025, then tumbled by 287.44% to -$1.2 million in 2026.
- Business Quant data shows LAB's Change in Account Payables at -$1.2 million in Q1 2026, $653000.0 in Q4 2025, and $946000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Standard Biotools | 319.06 Mn | -136.11 Mn | 11.31 Mn | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | 653,000.00 |
| Dec 31, 2025 | 653,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Jun 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | -578,000.00 |
| Mar 31, 2025 | -578,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | -2.19 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | -410,000.00 |
| Jun 30, 2024 | -410,000.00 |
| Mar 31, 2024 | -10.28 Mn |
| Mar 31, 2024 | -10.28 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Dec 31, 2023 | 2.10 Mn |